Kala Pharmaceuticals Inc. buy Oppenheimer Holdings Inc.
Start price
02.06.25
/
50%
€3.07
Target price
02.06.26
€13.19
Performance (%)
-57.42%
Price
30.09.25
€1.70
Summary
This prediction is currently active. The BUY prediction by Oppenheimer_Holdings for Kala Pharmaceuticals Inc. is performing very badly with a performance of -57.42%. This prediction currently runs until 02.06.26. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Kala Pharmaceuticals Inc. | -88.914% | -88.914% |
| iShares Core DAX® | 1.631% | -0.020% |
| iShares Nasdaq 100 | 1.073% | 5.074% |
| iShares Nikkei 225® | -0.615% | 5.550% |
| iShares S&P 500 | 1.061% | 3.163% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Kala Pharmaceuticals diskutieren
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Ratings data for KALA provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.52
11.09.25
11.09.25
€28.21
11.09.26
11.09.26
-90.33%
30.09.25
30.09.25
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.39
19.08.24
19.08.24
€13.55
19.08.25
19.08.25
28.32%
20.08.25
20.08.25
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.29
01.04.24
01.04.24
€13.96
01.04.25
01.04.25
-32.11%
02.04.25
02.04.25